HVT
Haverty Furniture Companies, Inc.
HVT has lower modeled downside risk, despite its lower overall score.
LCID
Lucid Group, Inc.
LCID has a slight edge over HVT overall, supported by stronger valuation and stronger fundamentals.
HVT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Stable | |
| Stable | |
| Strong |
HVT's balance sheet is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its revenue.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
HVT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.9x | $8.85 | -66% |
| Fair | 9.8x | $14.54 | -44% |
| Forward | 15x | $25.99 | — |
| Expensive | 16x | $23.69 | -8.8% |
| Current | 17x | $25.99 | — |
Historical ranges are pointers, not guarantees.
HVT's PE is in its expensive range at 17x. If earnings grow as analysts expect, today's price would be 15x next year's earnings.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
HVT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for HVT, with profitability improving. However, they disagree widely on these estimates.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
HVT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.79 | +20% |
| Q2 2025 | $1.17 | -50% |
| Q1 2025 | $1.28 | -54% |
| Q4 2024 | $1.19 | -65% |
| Q3 2024 | $1.60 | -59% |
| Q2 2024 | $2.33 | -46% |
| Q1 2024 | $2.76 | -44% |
| Q4 2023 | $3.36 | -36% |
| Q3 2023 | $3.88 | -25% |
HVT has the stronger earnings trend. Trailing diluted EPS is down 6.9% for HVT versus LCID down 224%.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
HVT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $194.9M | +7.7% |
| Q1 2026 | $189.1M | +4.1% |
| Q4 2025 | $201.9M | +9.5% |
| Q2 2025 | $181M | +1.3% |
| Q1 2025 | $181.6M | -1.3% |
| Q4 2024 | $184.4M | -13% |
| Q3 2024 | $175.9M | -20% |
| Q2 2024 | $178.6M | -13% |
HVT has the stronger quarterly revenue trend. Revenue is up 12% for HVT versus up 4.1% for LCID.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.2% | N/A |
| Q2 2026 | 3.3% | +1.8 points |
| Q1 2026 | 2.6% | +0.5 points |
| Q4 2025 | 4.8% | +0.2 points |
| Q2 2025 | 1.5% | -1.2 points |
| Q1 2025 | 2.1% | +1.2 points |
| Q4 2024 | 4.5% | -3.4 points |
| Q3 2024 | 2.8% | -6.8 points |
HVT has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID's revenue has grown year over year for 11 quarters in a row: $350M last quarter, up 4.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
HVT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $18.1M | +996% |
| Q1 2026 | -$9.9M | -36600% |
| Q4 2025 | $3M | -67% |
| Q2 2025 | $1.6M | -66% |
| Q1 2025 | $27K | +$3.3M |
| Q4 2024 | $9.1M | -18% |
| Q3 2024 | $16.1M | -52% |
| Q2 2024 | $4.9M | +$9.6M |
HVT has the stronger cash trend. Its trailing FCF is down 34% versus its history, compared with LCID at down 75%.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
HVT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -5.1% | -832K shares |
| 1 year | -5.1% | -832K shares |
| 3 years | -6.9% | -1.2M shares |
| 5 years | -17% | -3.2M shares |
| Available history | -21% | -4.1M shares |
HVT has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $14.6M |
| Q1 2026 | $2M |
| Q4 2025 | $2.8M |
| Q2 2025 | $999,000 |
| Q1 2025 | $2M |
| Q4 2024 | $5M |
| Q3 2024 | — |
HVT spent $19M buying back its own shares over the past year.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
HVT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.1x | Net Cash |
| Q2 2025 | 2.1x | Moderate |
| Q1 2025 | 2.1x | Moderate |
| Q4 2024 | 2.1x | Moderate |
| Q3 2024 | 1.7x | Healthy |
| Q2 2024 | 1.5x | Healthy |
| Q1 2024 | 1.3x | Healthy |
| Q4 2023 | 1.1x | Healthy |
HVT has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HVT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.6 | Neutral |
| Stochastic | 36.5 | Neutral |
HVT's weekly RSI is 49 (neutral) and its Stochastic is 36 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
HVT PE vs Consumer Cyclical Sector
| Metric | HVT | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 2.9% below |
| PE % | 95 | 47 | 48 pts above |
HVT is trading at 17x earnings, in line with the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
HVT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.6 | 5.8% below |
| 20 week MA | $27.1 | 4.1% below |
| 50 week MA | $25.0 | 3.8% above |
| 100 week MA | $23.2 | 12% above |
| 200 week MA | $26.6 | 2.1% below |
HVT has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
HVT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.1 | $28.4 | +41% |
| 2021 | $28.4 | $30.5 | +7.5% |
| 2022 | $30.5 | $30.7 | +0.7% |
| 2023 | $30.7 | $35.5 | +16% |
| 2024 | $35.5 | $22.1 | -38% |
| 2025 | $22.1 | $24.1 | +9% |
| 2026 YTD | $24.1 | $26.0 | +7.8% |
HVT has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.